SEMAGLUTIDE AND TIRZEPATIDE IN TYPE 2 DIABETES: PATIENT CHARACTERISTICS AND WEIGHT-RELATED OUTCOMES IN THE REAL-WORLD SETTING

被引：0
|
作者：
Althoff, A. [1 ]
Rasouliyan, L. [1 ]
机构：
[1] OMNY Hlth, Atlanta, GA USA
来源：
VALUE IN HEALTH | 2024年 / 27卷 / 06期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
HSD104
引用
收藏
页码：S238 / S239
页数：2
相关论文
共 50 条
  • [41] Clinical outcomes associated with the use of oral semaglutide in an adult population with type 2 diabetes in Canada: a prospective real-world study (PIONEER REAL Canada)
    Reichert, S. M.
    Amadid, H.
    Braae, U. C.
    Bradley, R. M.
    Kim, J.
    Soo, V.
    Yale, J. -F.
    Jain, A.
    DIABETOLOGIA, 2023, 66 (SUPPL 1) : S338 - S339
  • [42] Real-world use and effectiveness of tirzepatide among people without evidence of type 2 diabetes in the United States
    Hankosky, Emily R.
    Desai, Karishma
    Chinthammit, Chanadda
    Grabner, Michael
    Stockbower, Grace
    He, Xuanyao
    Mojdami, Donna
    Wenziger, Cachet
    Gibble, Theresa Hunter
    DIABETES & METABOLISM, 2025, 51 (03)
  • [43] Once-weekly subcutaneous semaglutide treatment for persons with type 2 diabetes: Real-world data from a diabetes out-patient clinic
    Hansen, Katrine B.
    Svendstrup, Mathilde
    Lund, Asger
    Knop, Filip K.
    Vilsboll, Tina
    Vestergaard, Henrik
    DIABETIC MEDICINE, 2021, 38 (10)
  • [44] Real-World Effectiveness among Patients with Type 2 Diabetes (T2D) Initiating Tirzepatide (TZP)
    Mody, Reema
    Desai, Karishma
    Teng, Chia-Chen
    Reznor, Gally
    Stockbower, Grace
    Grabner, Michael
    Benneyworth, Brian D.
    DIABETES, 2024, 73
  • [45] PIONEER REAL Japan: Baseline characteristics of a multicenter, prospective, real-world study of oral semaglutide in adults with type 2 diabetes in clinical practice in Japan
    Suzuki, Ryo
    Amadid, Hanan
    Major-Pedersen, Atheline
    Yabe, Daisuke
    JOURNAL OF DIABETES INVESTIGATION, 2024, 15 (08) : 1047 - 1056
  • [46] Effectiveness of Dapagliflozin in Treating Type 2 Diabetes Mellitus in a Real-World Indian Setting
    Jadhav, Uday M.
    Chawla, Manoj
    Rai, Sandeep
    Manjula, S.
    Kumar, M. Krishna
    JOURNAL OF DIABETOLOGY, 2025, 16 (02) : 176 - 181
  • [47] Real-World 12-Month Weight Loss Outcomes of Tirzepatide-The Mayo Clinic Experience
    Fansa, Sima
    Tama, Elif
    Safwan, Nancy
    Ghusn, Wissam
    Anazco, Diego
    Acosta, Andres
    Hurtado, Maria D.
    DIABETES, 2024, 73
  • [48] Real world use of tirzepatide in the treatment of type 2 diabetes in an Arab population
    Buckley, Adam
    Suliman, Sara
    Allum, Matthew
    Mohammed, Nagi
    Lessan, Nader
    le Roux, Carel W.
    Suliman, Mohamed
    DIABETES OBESITY & METABOLISM, 2024, 26 (08): : 3381 - 3391
  • [49] PREDICTORS AND CLINICAL OUTCOMES OF TREATMENT INTENSIFICATION IN PATIENTS WITH TYPE 2 DIABETES UNCONTROLLED ON BASAL INSULIN IN A REAL-WORLD SETTING
    Kallenbach, Lee
    Shui, Amy M.
    Cheng, Wendy Y.
    Fan, Tao
    Hu, Wenli
    Zichlin, Miriam L.
    Duh, Mei Sheng
    Ye, Fen
    Levin, Philip A.
    ENDOCRINE PRACTICE, 2018, 24 (09) : 805 - 814
  • [50] Real-World Impact of Once-Weekly Injectable Semaglutide on Weight, BMI, and HbA1c Outcomes in Type 2 Diabetes-An Observational Study (PAUSE)
    Amamoo, James
    Doshi, Riddhi P.
    Noone, Joshua
    Xie, Lin
    Gamble, Cory L.
    Guevarra, Mico
    Divino, Victoria
    Chen, Justin
    King, Aaron A.
    DIABETES, 2024, 73
12345